Clinical trial patients had two fewer headaches a month compared with those who received a placebo
This gene therapy for vision loss will initially cost $850,000
The pricey therapy is designed for adults with advanced lymphoma
The leukemia treatment approval opens up a new front for gene therapies in the U.S.
The experimental treatment will now face review by the agency
Scientists from all over the country are calling for an end to a immigration ban that could potentially affect thousands of scientists working in the U.S.
The result could be a major setback for the strategy of attacking amyloid plaques
Priorities at the NIH, the BRAIN Initiative, drug price controls and more initiatives could shift in major ways
The gene therapy could save kids with severe combined immune deficiency
Standard chemo blamed, experimental immune therapy cleared
An immune system booster called CAR-T appears to cause lethal brain injury
As opioid addiction soars, biotech companies eye a genetic mutation in people who feel no pain